Diclofenac Poses Similar Risks as COX-2 InhibitorsDiclofenac Poses Similar Risks as COX-2 Inhibitors

The committee says the benefits of diclofenac exceed the known risks and that physicians should take the same precautions to minimize thromboembolic risk as they do with patients treated with selective COX-2 inhibitors. Heartwire
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news